(Q43417859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

1 reference

systemic lupus erythematosus

0 references

author

Guillermo Ruiz-Irastorza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jose-Gabriel Erdozain

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

M V Egurbide

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

J I Pijoan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

M Garmendia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

I Villar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A Martinez-Berriotxoa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

C Aguirre

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

577-583

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Biochemical characterization of ADP-ribose polymer metabolism in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Mortality and causes of death in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

The cardiovascular burden of lupus: a complex challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Systemic lupus erythematosus and accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Premature atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Sequential therapies for proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306071872

21 January 2018

Identifiers

DOI

10.1177/0961203306071872

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17080912%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference